The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Nature Reviews Cancer 16, 463 (2016).
doi:10.1038/nrc.2016.49
Authors: Xiao Zhen Zhou & Kun Ping Lu
Targeted drugs have changed cancer treatment but are often ineffective in the long term against solid tumours, largely because of the activation of heterogeneous oncogenic pathways. A central common signalling mechanism in many of these pathways is proline-directed phosphorylation, which is regulated by many kinases
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Xiao Zhen ZhouKun Ping Lu Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology